Mission Pharmacal's Innovative Partnerships Fuel Rapid Growth

Company expands manufacturing, distribution, dermatology, and primary care offerings.

News provided by

Jun 18, 2015, 03:09 ET

SAN ANTONIO, June 18, 2015 /PRNewswire/ -- Mission Pharmacal Company has implemented a diversification strategy utilizing partnerships and acquisitions to continue to build on the company's nearly seven decades of success and excellence. President Neill "Gobie" Walsdorf, Jr. announced earlier this month that the Mission family of companies has expanded its specialty manufacturing capabilities with the acquisition of the assets of ProSolus Pharmaceuticals, LP, headquartered in Miami, Florida.

"The acquisition of ProSolus gives Mission exceptional expertise in the development and manufacturing of sophisticated and convenient transdermal (through the skin) drug delivery products to treat a variety of health conditions," says Walsdorf. "We're excited that we now have the opportunity to bring the convenience of well-designed and effective transdermal patches to healthcare providers and patients across the country."

The acquisition of ProSolus and its complete transdermal manufacturing operation further adds to Mission's already broad and progressive manufacturing vision. The company's state-of-the-art manufacturing campus in Boerne, Texas, features the latest high-capacity equipment for production of tablets, gels, liquids, creams, and semi-solids. Mission's expertise in solid dose tablet manufacturing has earned it international manufacturing agreements, including manufacturing Citracal® for Bayer Consumer Care and its affiliate companies.

By creating select forward-looking national and international partnerships, the company continues to grow and improve its portfolio with leading prescription and over-the-counter healthcare solutions in its core therapeutic areas of focus including women's health, urology, pediatrics, and dermatology with newly expanded reach into primary care and long-term care markets. The company formed wholly-owned subsidiaries Alamo Pharma Services, a specialized turnkey contract sales organization founded in 2011, and BioComp Pharma, a generic drug marketer started in 2009.

Through Alamo Pharma Services, Mission offers full commercial support to its own sales teams as well as several partner pharmaceutical companies. Alamo also offers an exceptional customized prescription drug sampling solution for direct-to-physician promotion for turnkey management systems with electronic data interchange (EDI) capabilities, and for national and international distribution services to clients' warehouses or directly to end users.

Mission's most rapidly growing area is its dermatology division founded in 2012 to help healthcare providers address chronic and one-time dermatological conditions affecting quality of life. The company's specially trained dermatology sales force already spans across the United States. These field representatives work closely with the healthcare community to provide product support and education to patients. Mission dermatology offerings effectively treat acne, atopic dermatitis, secondary bacterial infections and skin inflammation. Mission anticipates further expansion in the dermatology arena later this year.

Mission took another significant step in 2014 with the launch of a new primary care sales force to help reach more physicians and patients with select innovative dermatology, women's health, and pediatric products. The primary care sales team's strategic focus complements the work of Mission's specialty sales forces. Current product development, additional commercial partnerships, and acquisitions are expected to maximize the impact of this team as well as expand their reach.

On the international front, Mission has established consumer and prescription partnerships with the U.K. in two separate ventures to provide greater access for Mission's products in Europe. "These recent expansions are taking the company to a whole new level of national and global reach," says Walsdorf. "The years ahead promise to be exciting as Mission Pharmacal looks forward to the future to continue our history of meeting healthcare needs with the most innovative and effective products through both organic growth and our unique ability to partner with other companies."

To learn more about Mission Pharmacal Company and their business model or to discuss business opportunities, please visit missionpharmacal.com.

About Mission Pharmacal Company

Logo - http://photos.prnewswire.com/prnh/20140320/PH87885LOGO

SOURCE Mission Pharmacal Company